11 – 20 of 35
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Unraveling Parkinson's disease heterogeneity using subtypes based on multimodal data
(
- Contribution to journal › Article
-
Mark
Decreased CSF oxytocin relates to measures of social cognitive impairment in Huntington's disease patients
(
- Contribution to journal › Article
-
Mark
A relatively common hypomorphic variant in WARS2 causes monogenic disease
(
- Contribution to journal › Debate/Note/Editorial
- 2021
-
Mark
Digital health technology for non-motor symptoms in people with Parkinson's disease : Futile or future?
(
- Contribution to journal › Scientific review
-
Mark
The neurological and neuropsychiatric spectrum of adults with late-treated phenylketonuria
(
- Contribution to journal › Article
-
Mark
Validation and clinical value of the MANAGE-PD tool : A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications
(
- Contribution to journal › Article
-
Mark
Dopaminergic and serotonergic alterations in plasma in three groups of dystonia patients
(
- Contribution to journal › Article
- 2020
-
Mark
A detailed description of the phenotypic spectrum of North Sea Progressive Myoclonus Epilepsy in a large cohort of seventeen patients
(
- Contribution to journal › Article
-
Mark
New generation genetic testing entering the clinic
(
- Contribution to journal › Article
-
Mark
The late stage of Parkinson's –results of a large multinational study on motor and non-motor complications
(
- Contribution to journal › Article